MDS Forms Committee to Review 'Alternatives'

The formation of the committee and startegic review follow a restructuring last year and decline in fourth-quarter 2008 revenues.

Full-text access for registered users only. Existing users login here.
New to GenomeWeb? Register here quickly for free access.